Carcinoma of bladder Localized | Metastatic Neoplasm to the Bladder | Cancer of Urinary Tract Localized | Cancer of Urinary Tract metastatic | Prostate carcinoma Localized | Secondary malignant neoplasm of prostate | Disease Organ Primary | Secondary malignant neoplasm of bone eligible | Secondary malignant neoplasm of soft tissues eligible | Transurethral Resection of Prostate | Transurethral bladder excision
Item
patients with localized and/or metastatic bladder/urothelial or prostate cancer who have disease in the primary organ, biopsy accessible bone metastases (collaborating radiologists will determine if bone metastasis is appropriate for biopsy) or soft tissue metastases are eligible; men and women without cancer are eligible to have blood or normal tissue collected if acquired as part of non-research procedures (e.g. transurethral resection of the prostate or bladder); in patients without malignancy, no additional tissue beyond that necessary for care will be procured
boolean
C0699885 (UMLS CUI [1,1])
C0392752 (UMLS CUI [1,2])
C0347011 (UMLS CUI [2])
C0751571 (UMLS CUI [3,1])
C0392752 (UMLS CUI [3,2])
C0751571 (UMLS CUI [4,1])
C1522484 (UMLS CUI [4,2])
C0600139 (UMLS CUI [5,1])
C0392752 (UMLS CUI [5,2])
C0347001 (UMLS CUI [6])
C0012634 (UMLS CUI [7,1])
C0178784 (UMLS CUI [7,2])
C0205225 (UMLS CUI [7,3])
C0153690 (UMLS CUI [8,1])
C1548635 (UMLS CUI [8,2])
C0684686 (UMLS CUI [9,1])
C1548635 (UMLS CUI [9,2])
C0040771 (UMLS CUI [10])
C0565251 (UMLS CUI [11])
Informed Consent
Item
ability to adequately understand and give informed consent
boolean
C0021430 (UMLS CUI [1])
Disorder of soft tissue Local | Disorder of soft tissue metastatic | Bone Disease Local | Bone Disease metastatic | Site Biopsy Possible | Complication Risk Minimal
Item
local or metastatic disease to soft tissue or bone at sites accessible to biopsy with minimal risk of complications
boolean
C0263978 (UMLS CUI [1,1])
C0205276 (UMLS CUI [1,2])
C0263978 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C0005940 (UMLS CUI [3,1])
C0205276 (UMLS CUI [3,2])
C0005940 (UMLS CUI [4,1])
C1522484 (UMLS CUI [4,2])
C1515974 (UMLS CUI [5,1])
C0005558 (UMLS CUI [5,2])
C0332149 (UMLS CUI [5,3])
C0009566 (UMLS CUI [6,1])
C0035647 (UMLS CUI [6,2])
C0547040 (UMLS CUI [6,3])
Platelet Count measurement
Item
platelet count > 50,000
boolean
C0032181 (UMLS CUI [1])
White Blood Cell Count procedure
Item
white blood cell (wbc) > 1,500
boolean
C0023508 (UMLS CUI [1])
Hemoglobin measurement
Item
hemoglobin (hgb) > 8.0
boolean
C0518015 (UMLS CUI [1])
International Normalized Ratio
Item
international normalized ratio (inr) < 1.5
boolean
C0525032 (UMLS CUI [1])
Partial Thromboplastin Time measurement
Item
partial thromboplastin time (ptt) < 45
boolean
C0030605 (UMLS CUI [1])
Absence Prolonged bleeding after surgery Etiology Unknown
Item
no history of excessive unexplained bleeding from previous surgery
boolean
C0332197 (UMLS CUI [1,1])
C4021646 (UMLS CUI [1,2])
C0015127 (UMLS CUI [1,3])
C0439673 (UMLS CUI [1,4])
Chronic anticoagulation Unable to discontinue | Warfarin Unable to discontinue | Lovenox Unable to discontinue
Item
patients unable to stop chronic anticoagulation with warfarin or lovenox for less than 3 days
boolean
C0694554 (UMLS CUI [1,1])
C1548265 (UMLS CUI [1,2])
C0043031 (UMLS CUI [2,1])
C1548265 (UMLS CUI [2,2])
C0728963 (UMLS CUI [3,1])
C1548265 (UMLS CUI [3,2])
Communicable Disease Serious | Communicable Disease Uncontrolled
Item
serious or uncontrolled infection
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Vascular Endothelial Growth Factor Inhibitors | Avastin
Item
treatment with a vascular endothelial growth factor (vegf) inhibitor (such as avastin) within the past 28 days
boolean
C2267120 (UMLS CUI [1])
C1135130 (UMLS CUI [2])